Groundbreaking research focusing on multiple myeloma and various lymphomas, evaluating novel therapeutic combinations and treatment strategies for both newly diagnosed and relapsed patients.

Multiple Myeloma Treatments
B-Cell Lymphoma Therapies
T-Cell Lymphoma Studies

Innovative approaches combining immunotherapy with traditional treatments to improve patient outcomes.

02 Leukemia Research

Comprehensive studies on acute lymphoblastic leukemia and acute myeloid leukemia, exploring new immunotherapeutic agents and stem cell transplantation protocols.

Novel Immunotherapy Approaches
Stem Cell Transplantation
Treatment Optimization

Focus on improving survival rates through targeted therapies and personalized treatment strategies.

03 Neurological Disorders

Innovative research investigating potential treatments for Alzheimer's disease, including studies on caffeine's effects on cognitive decline in early-to-moderate stages.

Cognitive Function Studies
Drug Development
Treatment Efficacy

Exploring new therapeutic approaches for neurodegenerative conditions.

04 Oncology Studies

Advanced research in non-small cell lung cancer treatment, examining combination therapies including immunotherapy and radiation.

Immunotherapy Combinations
Radiation Treatment
Advanced Stage Cancer

Innovative approaches to treating advanced-stage cancers with combined therapeutic modalities.

Back to France All countries

Clinical trials in Dunkirk – page 2

23 trials in Dunkirk

T-cell type acute leukaemia

Evaluating venetoclax with drug combination in relapsed/refractory T‑cell acute lymphoblastic leukemia patients

Plasma cell myeloma

Study on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant

Immune thrombocytopenia

Study of rituximab and belimumab combination compared to rituximab alone in adults with persistent or chronic immune thrombocytopenia (ITP)

Plasma cell myeloma

Study Comparing Lenalidomide, Daratumumab, and Dexamethasone for Frail Patients with Untreated Multiple Myeloma Not Eligible for High-Dose Therapy

Plasma cell myeloma

Study of Teclistamab with Daratumumab or Lenalidomide for Elderly Patients with Newly Diagnosed Multiple Myeloma

Peripheral T-cell lymphoma unspecified

Study of Lacutamab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

Follicular lymphoma

Study of Zanubrutinib and Obinutuzumab for Patients with Relapsed or Refractory Follicular Lymphoma

Anal squamous cell carcinoma

Study Comparing Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil to Standard Treatment for Patients with Advanced Anal Cancer

Intervertebral disc protrusion+2

Study on Gabapentin and Placebo for Short-Term Relief of Acute Lower Back Pain from Herniated Disc in Adults

Plasma cell myeloma

Study on Isatuximab, Lenalidomide, and Dexamethasone for Elderly Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Acute myeloid leukaemia

Study on Improving Survival in Acute Myeloid Leukemia for Adults Aged 18-60 Using Idarubicin, Daunorubicin, Cytarabine, and Mycophenolic Acid

Filter the trials

Other cities in France

Clinical research in Dunkirk

Prefer not to search? Our Concierge searches the trials for you.

Clinical trials in Dunkirk – page 2

23 trials in Dunkirk

Intervertebral disc protrusion+2

Other cities in France

Related

Clinical research in Dunkirk

Prefer not to search? Our Concierge searches the trials for you.